Dr. Boman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4701 Ogletown Stanton Rd
Helen F Graham Cancer Center
Newark, DE 19713Phone+1 302-623-4205Fax+1 215-955-2340- Is this information wrong?
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1982 - 1984
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1980 - 1982- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1977 - 1980
University of Minnesota Medical SchoolClass of 1976
Certifications & Licensure
DC State Medical License 1983 - Present
DE State Medical License 2007 - 2025
PA State Medical License 1998 - 2024
MD State Medical License 1983 - 2020
IA State Medical License 1996 - 2000
TX State Medical License 1985 - 1987
MN State Medical License 1978 - 1987- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery Start of enrollment: 2010 Mar 01
Publications & Presentations
PubMed
- 5 citationsHOXA9 Overexpression Contributes to Stem Cell Overpopulation That Drives Development and Growth of Colorectal Cancer.Brian Osmond, Caroline O B Facey, Chi Zhang, Bruce M Boman> ;International Journal of Molecular Sciences. 2022 Jun 18
- 31 citationsRetinoids as Chemo-Preventive and Molecular-Targeted Anti-Cancer Therapies.Victoria O. Hunsu, Caroline O. B. Facey, Jeremy Z. Fields, Bruce M. Boman> ;International Journal of Molecular Sciences. 2021 Jul 20
- 14 citationsThe Role of miRNAs, miRNA Clusters, and isomiRs in Development of Cancer Stem Cell Populations in Colorectal Cancer.Victoria A. Stark, Caroline O. B. Facey, Vignesh Viswanathan, Bruce M. Boman> ;International Journal of Molecular Sciences. 2021 Jan 31
- Join now to see all
Journal Articles
- The Anti-Cancer Effect of Retinoic Acid Signaling in CRC Occurs via Decreased Growth of ALDH+ Colon Cancer Stem Cells and Increased Differentiation of Stem CellsBruce Boman, MD, Oncotarget
Press Mentions
ChristianaCare Research May Result in 'More Precise' Advanced Colorectal Cancer TreatmentApril 5th, 2023- Scientists Discover Second Key Pathway in Colon Cancer Stem Cell GrowthOctober 29th, 2020
Key Signaling Pathway Could Lead to New Targets in Colorectal CancerDecember 20th, 2018
Grant Support
- AP4 Center For Studies On Hereditary Colorectal CancerNational Cancer Institute2004
- Proteomic Analyses For GI Stem Cell Markers &MechanismsNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2004
- Markers For Stem Cell-Like Colonic Crypt Base CellsNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2004
- Characterizing Murine GI Stem Cells: New Molecular ToolsNational Cancer Institute2003–2004
- Core--Gastrointestinal CancerNational Cancer Institute2001–2002
- Approach For Colon Cancer Therapy Using APC PeptidesNational Cancer Institute1996–1998
Professional Memberships
- Member
Hospital Affiliations
ChristianaCareNewark, Delaware
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
